Kjetil Taskén

Lauras AS develops drugs for immune stimulating therapy. It develops and commercializes therapeutic products, other immune deficiencies and certain types of cancer in HIV/AIDS based on proprietary technology. The company was founded by Kjetil Taskén in 1998 and is headquartered in Oslo, Norway.

Bio-Medisinsk Innovasjon AS engages in the development of biotechnology, bio-medical and pharmaceutical businesses. The firm acts as an investor and incubator for start-ups. The company was founded in 2004 and is headquartered in Oslo, Norway.

siRNAsense AS focuses on developing pipeline drugs. Its sources projects include Biotechnology Centre of Oslo, Centre for Molecular Biology and Neuroscience, Rikshospitalet-Radiumhospitalet HF and University of Oslo. The company was founded in December 2004 and is headquartered in Oslo, Norway.

The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway.

Oslo universitetssykehus HF operates local hospital, acute hospitals, and regional hospital for residents and has a number of national tasks. It carries out patient treatment, research, and trial treatments, gives advice and provides education. The company was founded on December 1, 2008 and is headquartered in Oslo, Norway.